Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 4

3(60.0%)

N/A

1(20.0%)

Phase 2

1(20.0%)

5Total

Phase 4(3)

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06876038Phase 2Not Yet Recruiting

Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions

Role: collaborator

NCT06604325Not ApplicableRecruiting

Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery.

Role: lead

NCT06103968Completed

Influence of Gastric Tube Presence in Upholding the Correct Placement of LMA Blockbuster

Role: lead

NCT03833947Phase 4Completed

Dexamethasone vs Bicarbonate to Intracuff Lignocaine 2% in General Anaesthesia

Role: lead

NCT03438253Completed

Unwanted Penile Engorgement in Pediatric Patients Under Anesthesia.

Role: lead

NCT02201784Phase 4Completed

Spinal Anaesthesia With Levobupivacaine 0.5% and Ropivacaine 0.75% for Lower Limb Orthopaedic Surgery

Role: lead

NCT00926341Phase 4Completed

The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome

Role: lead

All 7 trials loaded